Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Eli Lilly
LLY
|
$1.2B |
| 2 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
$1.17B |
| 3 |
Baker Hughes
BKR
|
$871M |
| 4 |
Gilead Sciences
GILD
|
$803M |
| 5 |
APC
Anadarko Petroleum
APC
|
$656M |
Top Sells
| 1 |
BHI
Baker Hughes
BHI
|
$1.3B |
| 2 |
DXC Technology
DXC
|
$800M |
| 3 |
TWX
Time Warner Inc
TWX
|
$671M |
| 4 |
Novartis
NVS
|
$472M |
| 5 |
VMW
VMware, Inc
VMW
|
$318M |
Sector Composition
| 1 | Financials | 24.34% |
| 2 | Healthcare | 19.07% |
| 3 | Communication Services | 15.79% |
| 4 | Technology | 14.69% |
| 5 | Energy | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MetLife
MET
$54.1B
| $2.06B | 1.66% | 39,681,890 -954,571 | -2% | -$49.6M |
|
27
AstraZeneca
AZN
$248B
| $1.9B | 1.53% | 56,200,178 -469,271 | -0.8% | -$15.9M |
|
28
UnitedHealth
UNH
$281B
| $1.88B | 1.51% | 9,605,624 -464,684 | -5% | -$91M |
|
|
TFCFA
29
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.87B | 1.5% | 70,904,262 +2,737,973 | +4% | +$72.2M |
|
30
Bristol-Myers Squibb
BMY
$96B
| $1.85B | 1.49% | 29,054,961 -524,500 | -2% | -$33.4M |
|
|
31
Eli Lilly
LLY
$657B
| $1.71B | 1.38% | 20,020,077 +14,028,125 | +234% | +$1.2B |
|
32
Walmart
WMT
$774B
| $1.65B | 1.32% | 21,055,702 -193,824 | -0.9% | -$15.1M |
|
33
Union Pacific
UNP
$133B
| $1.58B | 1.27% | 13,617,369 +135,340 | +1% | +$15.7M |
|
34
Suncor Energy
SU
$50.1B
| $1.41B | 1.13% | 40,236,200 +3,414,400 | +9% | +$120M |
|
35
Booking.com
BKNG
$181B
| $1.38B | 1.11% | 754,463 -22,370 | -3% | -$41M |
|
36
APA Corp
APA
$8.31B
| $1.37B | 1.1% | 29,938,979 +16,248 | +0.1% | +$744K |
|
|
S
37
DELISTED
Sprint Corporation
S
| $1.29B | 1.04% | 166,256,751 -5,215,785 | -3% | -$40.6M |
|
38
Baidu
BIDU
$32.8B
| $1.21B | 0.97% | 4,890,587 -788,700 | -14% | -$195M |
|
39
Celanese
CE
$5.22B
| $1.2B | 0.96% | 11,480,169 -277,010 | -2% | -$28.9M |
|
40
Target
TGT
$43.6B
| $1.2B | 0.96% | 20,264,017 +238,794 | +1% | +$14.1M |
|
|
MFGP
41
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.17B | 0.94% | +36,661,106 | New | +$1.17B |
|
42
Liberty Global Class C
LBTYK
$4.07B
| $1.16B | 0.93% | 35,541,105 +3,234,884 | +10% | +$106M |
|
43
JD.com
JD
$44.1B
| $1.13B | 0.91% | 29,608,191 -3,106,000 | -9% | -$119M |
|
44
NOV
NOV
$4.94B
| $1.11B | 0.9% | 31,182,566 -157,123 | -0.5% | -$5.61M |
|
45
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.07B | 0.86% | 9,141,495 -44,325 | -0.5% | -$5.21M |
|
46
Televisa
TV
$1.49B
| $990M | 0.8% | 40,148,717 -159,900 | -0.4% | -$3.94M |
|
47
Truist Financial
TFC
$60.4B
| $967M | 0.78% | 20,606,484 -108,435 | -0.5% | -$5.09M |
|
48
Medtronic
MDT
$119B
| $945M | 0.76% | 12,147,095 +563,224 | +5% | +$43.8M |
|
|
MXIM
49
DELISTED
Maxim Integrated Products
MXIM
| $872M | 0.7% | 18,278,516 -241,218 | -1% | -$11.5M |
|
|
50
Baker Hughes
BKR
$44.8B
| $871M | 0.7% | +23,798,371 | New | +$871M |
|